The new factor Xa inhibitor: Apixaban

S Bhanwra, K Ahluwalia - Journal of Pharmacology and …, 2014 - journals.sagepub.com
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …

[HTML][HTML] The new factor Xa inhibitor: Apixaban

S Bhanwra, K Ahluwalia - Journal of Pharmacology & …, 2014 - ncbi.nlm.nih.gov
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …

[HTML][HTML] The new factor Xa inhibitor: Apixaban.

S Bhanwra, K Ahluwalia - Journal of Pharmacology & …, 2014 - europepmc.org
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …

The new factor Xa inhibitor: Apixaban

S Bhanwra, K Ahluwalia - Journal of Pharmacology and …, 2014 - search.proquest.com
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …

The new factor Xa inhibitor: Apixaban

S Bhanwra, K Ahluwalia - Journal of pharmacology & …, 2014 - pubmed.ncbi.nlm.nih.gov
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …

The new factor Xa inhibitor: Apixaban.

S Bhanwra, K Ahluwalia - Journal of Pharmacology & …, 2014 - search.ebscohost.com
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …

The new factor Xa inhibitor: Apixaban

S Bhanwra, K Ahluwalia - Journal of Pharmacology and …, 2014 - go.gale.com
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …

The new factor Xa inhibitor: Apixaban.

S Bhanwra, K Ahluwalia - Journal of Pharmacology & …, 2014 - europepmc.org
Cardiovascular diseases are still the most important cause of morbidity and mortality
worldwide and anti-thrombotic treatment is widely used as a result. The currently used drugs …